Shai S. Erlich
Chief Tech/Sci/R&D Officer at Quark Pharmaceuticals, Inc.
Profile
Shai S.
Erlich is currently the President-US Operations & Chief Medical Officer at Quark Pharmaceuticals, Inc. He started this position in 2010.
Prior to his current role, he has a background in education, having obtained a graduate degree from Tel-Aviv University, an undergraduate degree from Ben-Gurion University of the Negev, and a doctorate degree from Icahn School of Medicine at Mount Sinai.
Shai S. Erlich active positions
| Companies | Position | Start |
|---|---|---|
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Chief Tech/Sci/R&D Officer | 26/09/2010 |
Training of Shai S. Erlich
| Ben-Gurion University of the Negev | Undergraduate Degree |
| Tel-Aviv University | Graduate Degree |
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Stock Market
- Insiders
- Shai S. Erlich
